|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/28 | (2015.01) |
| A61K 38/02 | (2013.01) | ||
| A61K 38/02 | (2006.01) | ||
| A61K 35/28 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/02 | (2018.01) |
| (11) | Patento numeris | 3478300 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17819499.9 |
| Europos patento paraiškos padavimo data | 2017-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2017/050722 |
| Data | 2017-06-29 |
| (87) | Numeris | WO 2018/002930 |
| Data | 2018-01-04 |
| (30) | Numeris | Data | Šalis |
| 201662356543 P | 2016-06-30 | US |
| (72) |
MAROM, Ehud , IL
BLEICH KIMELMAN, Nadav , IL
GRYNSPAN, Frida , IL
|
| (73) |
Stem Cell Medicine Ltd. ,
5 Kiryat Hamada Street, 91451 Jerusalem,
IL
Mapi Pharma Limited , 16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, IL |
| (54) | TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS |
| TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS |